HISTORY
- 2019
- Plan to establish a new production base at Shandong Province to create an innovative high-end APIs production base with gobal standard.
- 2018
- Acquired the “Suzhou Tianma Pharmaceutical Co.,Ltd.” and established Suzhou production base.
- 2017
- R&D center in nanjing moved to 5,000 square meter newly constructed state-of-the-art building in Nanjing Pukou Economic Development Zone.
- 2015
- The shareholding system was transformed and listed on the New Third Board. Stock code 834804.
- 2015
- Established independent R&D center in Nanjing for the research of new drugs, high-end generic API and intermediates.
- 2012
- Acquired Lanjian Pharmaceutical and established Huai'an Production Base.
